Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-26-066965
Filing Date
2026-02-24
Accepted
2026-02-24 16:06:52
Documents
78
Period of Report
2025-12-31

Document Format Files

Seq Description Document Type Size
1 10-K fblg-20251231.htm   iXBRL 10-K 4456249
2 EX-4.2 fblg-ex4_2.htm EX-4.2 69210
3 EX-21.1 fblg-ex21_1.htm EX-21.1 5135
4 EX-23.1 fblg-ex23_1.htm EX-23.1 5146
5 EX-31.1 fblg-ex31_1.htm EX-31.1 33505
6 EX-31.2 fblg-ex31_2.htm EX-31.2 33007
7 EX-32.1 fblg-ex32_1.htm EX-32.1 12838
8 GRAPHIC img139636105_0.jpg GRAPHIC 56267
9 GRAPHIC img139636105_1.jpg GRAPHIC 36495
  Complete submission text file 0001193125-26-066965.txt   13421573

Data Files

Seq Description Document Type Size
10 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fblg-20251231.xsd EX-101.SCH 1288750
81 EXTRACTED XBRL INSTANCE DOCUMENT fblg-20251231_htm.xml XML 2243357
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5150
FibroBiologics, Inc. (Filer) CIK: 0001958777 (see all company filings)

EIN.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41934 | Film No.: 26671565
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)